IN BRIEF: Renalytix targets Illinois and Iowa for US expansion

Renalytix PLC - London-based diagnostics company focused on kidney health - Says upper Midwest ...

Alliance News 17 August, 2022 | 4:45PM
Email Form Facebook Twitter LinkedIn RSS

Renalytix PLC - London-based diagnostics company focused on kidney health - Says upper Midwest region of the US - specifically Illinois and Iowa - are now its main commercial expansion markets for KidneyIntelX. Private insurance coverage contracts secured and effective during the quarter ending September 30, include Blue Cross Blue Shield Illinois, with an estimated over 8 million covered lives and Molina Healthcare Illinois, estimated 500,000 covered lives. This complements coverage already secured with Wellmark Blue Cross Blue Shield in Iowa and South Dakota at estimated 2.1 million covered lives.

Further, Renalytix has contracted with Illinois Medicaid as a provider. Illinois Medicaid is estimated to provide medical insurance to over 20% of, or 3.3 million, Illinois residents and the contracts with BCBS and Molina provide insurance coverage for a significant proportion of that population.

Illinois will now play a critical part in the KidneyIntelX health equity strategy to help drive down disparities in community care for individuals with diabetes and kidney disease, it adds.

Current stock price: 100.00 pence

12-month change: down 88%

By Arvind Bhunjun; arvindbhunjun@alliancenews.com

Copyright 2022 Alliance News Limited. All Rights Reserved.

Email Form Facebook Twitter LinkedIn RSS

Securities Mentioned in Article

Security Name Price Change (%) Morningstar
Rating
Renalytix PLC 30.00 GBX 0.00 -

About Author

Alliance News

Alliance News provides Morningstar with continuously updating coverage of news affecting listed companies.

© Copyright 2024 Morningstar, Inc. All rights reserved.

Terms of Use        Privacy Policy        Modern Slavery Statement        Cookie Settings        Disclosures